PT327 Rick Doblin, Ph.D. Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine

Published: June 14, 2022, 1:44 p.m.

In this episode, David interviews Founder and Executive Director of MAPS, Rick Doblin, Ph.D. He discusses the abuse allegations unearthed in the recent \u201cCover Story\u201d podcast series, real-world evidence, and MAPS' future goals.\xa0

www.psychedelicstoday.com